# Hydromorphone Hydrochloride Injection: FDA shortage status > FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice. - Derived status: current - Source statuses: Current - FDA package records: 26 - Latest FDA row update: 08/17/2026 - Retrieved: 2026-08-22T15:54:11+00:00 ## FDA package and manufacturer records - Fresenius Kabi USA, LLC — Dilaudid, Injection, .2 mg/1 mL (NDC 76045-121-11) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-06) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-11) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Dilaudid, Injection, 2 mg/1 mL (NDC 76045-010-11) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-852-25) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-10) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-15) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-50) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 63323-853-25) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Hydromorphone Hydrochloride, Injection, 4 mg/1 mL (NDC 63323-854-10) — FDA availability: Available — updated: 08/04/2026 - Hikma Pharmaceuticals USA, Inc. — Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-0121-25) — FDA availability: Available — updated: 08/13/2026 - Hikma Pharmaceuticals USA, Inc. — Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-6254-01) — FDA availability: Unavailable — updated: 08/13/2026 - Hospira, Inc., a Pfizer Company — Hydromorphone Hydrochloride, Injection, 0.25 mg/ 0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-1805-01) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Hydromorphone Hydrochloride, Injection, 0.5 mg/0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-4264-01) — FDA availability: Limited Availability — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 0409-1283-37) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Hydromorphone Hydrochloride, Injection, 1 mg/1 mL Syringes (NDC 0409-1283-31) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0409-2634-01) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-1312-36) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-3365-10) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Hydromorphone Hydrochloride, Injection, 2 mg/1 mL Syringes (NDC 0409-1312-30) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Hydromorphone Hydrochloride, Injection, 4 mg/1 mL Syringes (NDC 0409-1304-31) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Hydromorphone Hydrochloride, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-2634-05) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Hydromorphone Hydrochloride, Injection, 500 mg/50 mL (10 mg/mL) (NDC 0409-2634-50) — FDA availability: Available — updated: 08/07/2026 - Teva Pharmaceuticals USA, Inc. — Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0018-01) — FDA availability: Available — updated: 08/17/2026 - Teva Pharmaceuticals USA, Inc. — Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0110-03) — FDA availability: Available — updated: 08/17/2026 - Teva Pharmaceuticals USA, Inc. — Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0113-03) — FDA availability: Available — updated: 08/17/2026 ## Sources and formats - [FDA openFDA source](https://api.fda.gov/drug/shortages.json) - [Canonical HTML](https://citefacts.com/shortages/hydromorphone-hydrochloride-injection) - [JSON record](https://citefacts.com/shortages/hydromorphone-hydrochloride-injection.json)